Target intelligence / Profile preview

Enterococcus surface protein (Esp) (Esp)

Target
Esp
Molecular classification
Surface protein, Adhesin, Microbial Surface Components Recognizing Adhesive Matrix Molecules (MSCRAMM)
01

Overview

Enterococcus surface protein (Esp) is a high-molecular-weight, cell-wall-associated protein primarily found in pathogenic strains of Enterococcus faecalis and Enterococcus faecium (UniProt Q9L9N1). It belongs to the MSCRAMM (Microbial Surface Components Recognizing Adhesive Matrix Molecules) family and is characterized by a large N-terminal domain followed by a series of tandem repeats (Sillanpää et al., 2004, PubMed: 15150608). Esp plays a critical role in the pathogenesis of enterococcal infections by promoting primary attachment to host surfaces and facilitating the development of complex biofilm structures, which protect the bacteria from host immune responses and antibiotic treatment (Toledo-Arana et al., 2001, PubMed: 11544235). The presence of the esp gene is strongly correlated with clinical isolates from urinary tract infections and endocarditis, often residing on a pathogenicity island (Shankar et al., 1999, PubMed: 10411911). As a therapeutic target, Esp is being investigated for the development of vaccines and monoclonal antibodies aimed at neutralizing its adhesive properties and preventing biofilm-associated chronic infections (He et al., 2008, PubMed: 18621124). Targeting Esp offers a strategy to reduce the virulence of multidrug-resistant enterococci without necessarily killing the bacteria, thereby exerting less selective pressure for resistance. This approach is particularly relevant given the increasing prevalence of vancomycin-resistant enterococci (VRE) in healthcare settings.

Other names
EspEnterococcal surface proteinSurface protein EspEsp protein
02

Mechanism of action

Inhibition of bacterial adhesion to host tissues and disruption of biofilm architecture by targeting the N-terminal or repeat domains of the protein.

03

Biological functions

Cell adhesionBiofilm formationHost colonizationImmune evasion
04

Disease associations

InfectionUrinary tract infectionEndocarditisBacteremia
05

Safety considerations

Impact on commensal Enterococcus strainsHigh sequence variability in repeat regionsPotential for immune escape
06

Interacting drugs

Anti-Esp monoclonal antibodies (experimental)

1 more in the full profile.

07

Biomarkers

esp gene presenceEsp protein expression

Beyond the preview

Go deeper on Enterococcus surface protein (Esp) (Esp).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Enterococcus surface protein (Esp) (Esp).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call